Neurotech International Limited Price (NTI.AX)

Stock Price

Low: Year Low
High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Fetching Data...

Shares Outstanding

911,961,998

(14.1705)%

Neurotech Performance History

Community Sentiment 0 votes
↑ 0% ↓ 0%

Description

Neurotech International Limited, together with its subsidiaries, engages in the research, design, development, and manufacture of medical devices and solutions in Australia. The company is focused on development and commercializing Mente platform, a platform technology to monitor and play role in home-based therapies. Its product includes Mente Autism for the diagnosis and treatment of autism. It also engages in executing of medical research projects; and developing of technological devices. The company was incorporated in 2016 and is based in Nedlands,... Read More

Sector: Healthcare

  • Previous Close Fetching Data...
  • Range $0.028-0.12
  • Market Cap 36.47M
  • Enterprise Value No Data
  • Avg Volume Fetching Data...
  • P/E Ratio Fetching Data...
  • Dividend Yield Fetching Data...

Industry: Medical - Devices

  • ceo: Dr. Anthony Filippis M.B.A., Ph.D.
  • IPO Date: November, 03, 2016
  • Country: AU
  • Currency: AUD
  • Headquaters: Nedlands, WA
  • Employees: 18

- Revenue from each product or segment:

Product or Segment Value: % - Total Last 3Y:
news-img

- Revenue by Region

Product or Segment Value: % - Total Last 3Y:
news-img
8 New Orders
close
Theme Customizer

Customize your theme

close

Theme variation